Top Abstract Purchase Related
Home
>
Node
>
Subnode

Gene Polymorphism Gln27glu Β2-Adrenergic Receptors in Patients with Ischemic Heart Disease as a Factor of Development and Progression of Obesity

Kadykova, O.; Kravchun, P.; Ryndina, N.; Gabisoniya, T.; Molotyagin, D.

Georgian Medical News 249: 59-62

2015

ISSN/ISBN: 1512-0112
PMID: 26719551
Document Number: 679958
Currently large numbers of genetic markers that are closely linked to the development of cardiovascular diseases and obesity are identified. The aim of our study was the study of polymorphism Gln27Glu β2-adrenergic receptor gene as a possible factor in the pathogenesis of obesity in patients with coronary heart disease. We conducted a comprehensive survey of 337 patients with coronary heart disease. All patients were divided into two groups according to the presence of obesity: the first group - patients with coronary artery disease with normal body weight (n=115), the second group - patients with coronary heart disease and obesity (n=222). The control group consisted of 35 healthy people. It was established that the presence of the G allele and genotype G/G Gln27Glu β2-adrenergic receptor gene are at risk of development and progression of obesity in patients with coronary heart disease.

Document emailed within 1 workday
Secure & encrypted payments

Manzoli, A.; Andreotti, F.; Varlotta, C.; Mollichelli, N.; Verde, M.; van de Greef, W.; Sperti, G.; Maseri, A. 1999: Allelic polymorphism of the interleukin-1 receptor antagonist gene in patients with acute or stable presentation of ischemic heart disease Cardiologia 44(9): 825-830
Peterlin, B.; Petrovic, D.; Zorc, M.; Keber, I. 2000: Deletion/insertion polymorphism in the angiotension-converting enzyme gene as a risk factor in the Slovenian patients with coronary heart disease Pflugers Archiv: European Journal of Physiology 439(3 Suppl): R40-R41
Thomsen, T.F. 2000: Obesity as a risk factor of ischemic heart disease Ugeskrift for Laeger 162(5): 677
Oksanen, L.; Mustajoki, P.; Kaprio, J.; Kainulainen, K.; Jänne, O.; Peltonen, L.; Kontula, K. 1996: Polymorphism of the beta 3-adrenergic receptor gene in morbid obesity International Journal of Obesity and Related Metabolic Disorders: Journal of the International Association for the Study of Obesity 20(12): 1055-1061
Golimbet, V.E.; Volel, B.A.; Kopylov, F.Y.; Dolzhikov, A.V.; Korovaitseva, G.I.; Kasparov, S.V.; Isaeva, M.I. 2015: Anxiety and Polymorphism Val66Met of BDNF gene Predictors of Depression Severity in Ischemic Heart Disease Kardiologiia 55(1): 9-13
Goracy, I. 2000: Polymorphism of genes coding for angiotensin i converting enzyme and methylenetetrahydrofolate reductase in patients with ischemic heart disease Annales Academiae Medicae Stetinensis 46: 97-108
Sobti, R.Chander.; Berhane, N.; Mehedi, S.Abedule.; Kler, R.; Hosseini, S.Ali.; Kuttiat, V.; Wanchu, A. 2010: Association and impact of XPG Asp 1104 His gene polymorphism in HIV 1 disease progression to AIDS among north Indian HIV seropositive individuals Molecular Biology Reports 37(1): 317-324
Sergienko, I.V.; Semenova, A.E.; Masenko, V.P.; Ezhov, M.V.; Gabrusenko, S.A.; Kukharchuk, V.V.; Belenkov, I.N. 2007: Effect of statin therapy on dynamics of vascular endothelial growth factor and fibroblast growth factor in patients with ischemic heart disease Kardiologiia 47(8): 4-7
Buziashvili, I.I.; Matskeplishvili, S.T.; Asymbekova, E.U.; Khapiĭ, I.K.; Kamardinov, D.K.; Buval'tsev, V.I. 2003: Effect of dipyridamole on blood levels of fibroblast growth factor and vascular endothelial growth factor in patients with ischemic heart disease Kardiologiia 43(6): 14-17
Zaĭkina, A.A.; Savinetskaia, G.A.; Gerok, D.V.; Marsheva, O.V.; Pogoda, T.V.; Generozov, E.V.; Syrkin, A.L. 2008: Genetic polymorphism in ischemic heart disease Kardiologiia 48(1): 62-65
Polozhentsev, S.D.; Rudnev, D.A. 1988: Status of lipid metabolism in patients with ischemic heart disease and its behavioral risk factor Kardiologiia 28(12): 101-102
Baturin, A.K.; Sorokina, E.I.; Pogozheva, A.V.; Peskova, E.V.; Makurina, O.N.; Tutel'ian, V.A. 2014: Regional features of obesity-associated gene polymorphism (rs9939609 FTO gene and gene Trp64Arg ADRB3) in Russian population Voprosy Pitaniia 83(2): 35-41
Liamina, N.P.; Khalfen, E.S.; Meerson, F.Z. 1991: Effects of stress and exercise tests on the functional state of cardiac performance and the state of adrenergic regulation in patients with ischemic heart disease Kardiologiia 31(4): 42-45
Sokolov, E.I.; Grishina, T.I.; Shtin, S.R. 2013: Effect of von Willebrand factor and endothelin-1 on formation of thrombotic status in patients with ischemic heart disease Kardiologiia 53(3): 25-30
Jin, Y.H.; Shen, X.L.; Wang, M.S.; Xu, X.M.; Liu, M.N.; Zhao, Z.S.; Zheng, J.Y. 2016: Association between the C46T polymorphism of coagulation factor Ⅻ gene and the involvement of factor Ⅻ activity in patients with unexplained recurrent spontaneous abortion Zhonghua Fu Chan Ke Za Zhi 51(8): 597-601
Wu, P.; Shu, Y.; Li, M.; Luo, H.; Zhang, G.; Tan, S. 2015: Study on the interaction between matrix metalloproteinases gene polymorphism and central obesity in nonalcoholic fatty liver disease Zhonghua Liu Xing Bing Xue Za Zhi 36(12): 1415-1418
Zhao, X.-y.; Zhang, M.-x.; Cheng, H.; Yan, Y.-k.; Wu, L.-j.; Shen, Y.; Mi, J. 2013: Risk of obesity-related gene polymorphism on the incidence and durative of childhood obesity Zhonghua Liu Xing Bing Xue Za Zhi 34(6): 560-565
Komarov, F.I.; Ol'binskaia, L.I.; Bragina, G.I. 1979: Effect of different groups of adrenergic beta receptor blockaders on the clinical course of the disease, work capacity and echocardiographic indicators in ischemic heart disease Terapevticheskii Arkhiv 51(8): 13-17
Chen, Y.; Xu, Y.; Zhou, L. 2001: Association of beta 3-adrenergic receptor gene with obesity in patients with type 2 diabetes mellitus Zhonghua Yu Fang Yi Xue Za Zhi 35(5): 333-335
Ohta, M.; Hashimoto, H.; Takano, T. 1995: Cardiac hypertrophy and ischemic heart disease in obesity Nihon Rinsho. Japanese Journal of Clinical Medicine 53 Suppl: 332-337